Další formáty:
BibTeX
LaTeX
RIS
@article{1399350,
author = {Iorio, A. and Blanchette, V. and Blatný, Jan and Collins, P. and Fischer, K. and Neufeld, E.},
article_location = {Hoboken},
article_number = {12},
doi = {http://dx.doi.org/10.1111/jth.13867},
keywords = {hemophilia A; hemophilia B},
language = {eng},
issn = {1538-7933},
journal = {Journal of Thrombosis and Haemostasis},
title = {Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH},
url = {http://dx.doi.org/10.1111/jth.13867},
volume = {15},
year = {2017}
}
TY - JOUR
ID - 1399350
AU - Iorio, A. - Blanchette, V. - Blatný, Jan - Collins, P. - Fischer, K. - Neufeld, E.
PY - 2017
TI - Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH
JF - Journal of Thrombosis and Haemostasis
VL - 15
IS - 12
SP - 2461-2465
EP - 2461-2465
PB - Wiley
SN - 15387933
KW - hemophilia A
KW - hemophilia B
UR - http://dx.doi.org/10.1111/jth.13867
L2 - http://dx.doi.org/10.1111/jth.13867
N2 - The ISTH SSC on Factor VIII/IX has previously issued guidelines for studies assessing the pharmacokinetics (PK) of factor concentrates [1, 2]. It suggested drawing 10 or 11 blood samples over a period of 32-48 h or 50-72 h, after infusing 25-50 IU kg-1 or 50-75 IU kg-1, respectively, for FVIII or FIX, in cohorts of 12-15 patients with a crossover design. Such PK studies are not ideal for tailoring the treatment of individual patients, mostly because of the requirement for several blood samples. Owing to broad interindividual variation, the individual disposition of FVIII and FIX cannot be predicted from morphometric characteristics and average PK parameters, but requires empirical assessment in each individual [3-6]. Previous guidance of this ISTH SSC described the PK methodology for the prediction of individual trough levels of FVIII [7]. The present communication, building on recent advances in the population pharmacokinetics (PopPK) of FVIII and FIX [8], adds to the former documents.
ER -
IORIO, A., V. BLANCHETTE, Jan BLATNÝ, P. COLLINS, K. FISCHER a E. NEUFELD. Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH. \textit{Journal of Thrombosis and Haemostasis}. Hoboken: Wiley, 2017, roč.~15, č.~12, s.~2461-2465. ISSN~1538-7933. Dostupné z: https://dx.doi.org/10.1111/jth.13867.
|
